Elanco Animal Health Incorporated

NYSE ELAN

Elanco Animal Health Incorporated Market Capitalization on January 14, 2025: USD 5.78 B

Elanco Animal Health Incorporated Market Capitalization is USD 5.78 B on January 14, 2025, a -22.43% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Elanco Animal Health Incorporated 52-week high Market Capitalization is USD 9.10 B on June 05, 2024, which is 57.34% above the current Market Capitalization.
  • Elanco Animal Health Incorporated 52-week low Market Capitalization is USD 5.65 B on January 10, 2025, which is -2.31% below the current Market Capitalization.
  • Elanco Animal Health Incorporated average Market Capitalization for the last 52 weeks is USD 7.17 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
NYSE: ELAN

Elanco Animal Health Incorporated

CEO Mr. Jeffrey N. Simmons
IPO Date Sept. 20, 2018
Location United States
Headquarters 2500 Innovation Way
Employees 9,300
Sector Consumer Staples
Industries
Description

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Similar companies

ITCI

Intra-Cellular Therapies, Inc.

USD 126.89

-0.24%

ESPR

Esperion Therapeutics, Inc.

USD 2.24

-1.75%

SIGA

SIGA Technologies, Inc.

USD 6.33

4.46%

IRWD

Ironwood Pharmaceuticals, Inc.

USD 3.65

-3.18%

ALKS

Alkermes plc

USD 28.50

0.53%

PCRX

Pacira BioSciences, Inc.

USD 20.55

-2.74%

LNTH

Lantheus Holdings, Inc.

USD 92.62

-2.15%

PBH

Prestige Consumer Healthcare Inc.

USD 75.78

1.54%

PAHC

Phibro Animal Health Corporation

USD 20.28

0.05%

VTRS

Viatris Inc.

USD 11.72

-0.68%

COLL

Collegium Pharmaceutical, Inc.

USD 33.18

-1.80%

StockViz Staff

January 15, 2025

Any question? Send us an email